Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

Clinical trial NCT00003895 · COMPLETED

Trial details

NCT number: NCT00003895
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IA Melanoma Stage IB Melanoma Stage IIA Melanoma Stage IIB Melanoma Stage IIC Melanoma Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma

Start date: 1999-04-01
Primary completion: 2013-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.